Aligos Therapeutics Statistics
Total Valuation
ALGS has a market cap or net worth of $96.61 million. The enterprise value is $30.82 million.
Important Dates
The next estimated earnings date is Tuesday, March 11, 2025, after market close.
| Earnings Date | Mar 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALGS has 3.71 million shares outstanding. The number of shares has increased by 246.07% in one year.
| Current Share Class | 3.59M |
| Shares Outstanding | 3.71M |
| Shares Change (YoY) | +246.07% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 4.73% |
| Owned by Institutions (%) | 20.21% |
| Float | 1.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.91 |
| Forward PS | 66.08 |
| PB Ratio | 1.73 |
| P/TBV Ratio | 1.93 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.81, with a Debt / Equity ratio of 0.18.
| Current Ratio | 3.81 |
| Quick Ratio | 3.58 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -146.69% and return on invested capital (ROIC) is -93.25%.
| Return on Equity (ROE) | -146.69% |
| Return on Assets (ROA) | -67.32% |
| Return on Invested Capital (ROIC) | -93.25% |
| Return on Capital Employed (ROCE) | -139.12% |
| Revenue Per Employee | $90,864 |
| Profits Per Employee | -$1.17M |
| Employee Count | 66 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALGS has paid $274,000 in taxes.
| Income Tax | 274,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.61% in the last 52 weeks. The beta is 2.46, so ALGS's price volatility has been higher than the market average.
| Beta (5Y) | 2.46 |
| 52-Week Price Change | +44.61% |
| 50-Day Moving Average | 31.42 |
| 200-Day Moving Average | 17.64 |
| Relative Strength Index (RSI) | 42.15 |
| Average Volume (20 Days) | 311,874 |
Short Selling Information
The latest short interest is 664,384, so 17.90% of the outstanding shares have been sold short.
| Short Interest | 664,384 |
| Short Previous Month | 597,297 |
| Short % of Shares Out | 17.90% |
| Short % of Float | 36.26% |
| Short Ratio (days to cover) | 1.44 |
Income Statement
In the last 12 months, ALGS had revenue of $6.00 million and -$76.95 million in losses. Loss per share was -$12.89.
| Revenue | 6.00M |
| Gross Profit | -70.50M |
| Operating Income | -93.86M |
| Pretax Income | -75.52M |
| Net Income | -76.95M |
| EBITDA | -92.68M |
| EBIT | -93.86M |
| Loss Per Share | -$12.89 |
Full Income StatementBalance Sheet
The company has $74.92 million in cash and $9.13 million in debt, giving a net cash position of $65.79 million or $17.73 per share.
| Cash & Cash Equivalents | 74.92M |
| Total Debt | 9.13M |
| Net Cash | 65.79M |
| Net Cash Per Share | $17.73 |
| Equity (Book Value) | 50.10M |
| Book Value Per Share | 15.07 |
| Working Capital | 58.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$85.00 million and capital expenditures -$109,000, giving a free cash flow of -$85.11 million.
| Operating Cash Flow | -85.00M |
| Capital Expenditures | -109,000 |
| Free Cash Flow | -85.11M |
| FCF Per Share | -$22.93 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,565.18% |
| Pretax Margin | -1,278.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALGS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -246.07% |
| Shareholder Yield | -246.07% |
| Earnings Yield | -79.65% |
| FCF Yield | -88.09% |
Analyst Forecast
The average price target for ALGS is $75.00, which is 188.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $75.00 |
| Price Target Difference | 188.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 79.71% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on August 19, 2024. It was a reverse split with a ratio of 0.04:1.
| Last Split Date | Aug 19, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.04:1 |
Scores
ALGS has an Altman Z-Score of -10.34 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -10.34 |
| Piotroski F-Score | 1 |